Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Dentsply Sirona Inc Stock Research

XRAY

35.19USD-0.10(-0.28%)Market Closed
Watchlist

Market Summary

USD35.19-0.10
Market Closed
-0.28%

XRAY Stock Price

XRAY RSI Chart

XRAY Valuation

Market Cap

7.4B

Price/Earnings (Trailing)

-7.24

Price/Sales (Trailing)

1.89

EV/EBITDA

-7.1

Price/Free Cashflow

22.3

XRAY Price/Sales (Trailing)

XRAY Profitability

EBT Margin

-29.76%

Return on Equity

-28.51%

Return on Assets

-13.53%

Free Cashflow Yield

4.48%

XRAY Fundamentals

XRAY Revenue

Revenue (TTM)

3.9B

Revenue Y/Y

0.49%

Revenue Q/Q

5.11%

XRAY Earnings

Earnings (TTM)

-1.0B

Earnings Y/Y

17.81%

Earnings Q/Q

473.91%

Price Action

52 Week Range

26.4843.24
(Low)(High)

Last 7 days

-3.7%

Last 30 days

-5.4%

Last 90 days

-9.4%

Trailing 12 Months

10.6%

XRAY Financial Health

Current Ratio

1.41

XRAY Investor Care

Dividend Yield

1.53%

Dividend/Share (TTM)

0.54

Buy Backs (1Y)

1.49%

Diluted EPS (TTM)

-4.77

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for XRAY

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-12
Campion Simon D
sold (taxes)
-1,107,120
36.65
-30,208
president, ceo & member of bod
2023-08-09
Brackett Erania
sold (taxes)
-9,502
38.47
-247
svp, chief marketing officer
2023-08-09
Frohning Andrea L.
acquired
-
-
7,798
svp, chro
2023-07-17
Johnson Robert Anthony
acquired
-
-
330
svp, chief supply chain office
2023-07-14
VARON LESLIE F
acquired
-
-
49.884
-
2023-07-14
Coleman Glenn
acquired
-
-
228
executive vp & cfo
2023-07-14
Vergis Janet S.
acquired
-
-
41.45
-
2023-07-14
HOLDEN BETSY D
acquired
-
-
93.091
-
2023-07-14
Wenzel Ilse Dorothea
acquired
-
-
41.45
-
2023-07-14
KRAEMER HARRY M JANSEN JR
acquired
-
-
75.005
-

1–10 of 50

Which funds bought or sold XRAY recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-13
CGC Financial Services, LLC
new
-
7,539
7,539
-%
2023-09-12
Farther Finance Advisors, LLC
added
67.83
3,988
9,605
-%
2023-08-28
Willow Creek Wealth Management Inc.
added
0.06
9,678
508,534
0.07%
2023-08-28
DT Investment Partners, LLC
unchanged
-
-25.00
1,035
-%
2023-08-25
Gould Capital, LLC
unchanged
-
134
7,244
0.01%
2023-08-23
HEADINVEST, LLC
reduced
-32.83
-349,900
690,313
0.15%
2023-08-23
Stonebridge Capital Advisors LLC
unchanged
-
74.00
4,002
-%
2023-08-22
COMERICA BANK
sold off
-
-
-
-%
2023-08-21
JOHN G ULLMAN & ASSOCIATES INC
reduced
-2.67
-41,158
4,886,840
0.75%
2023-08-21
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
reduced
-1.88
-
773,000
0.01%

1–10 of 48

Latest Funds Activity

Are funds buying XRAY calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own XRAY
No. of Funds

Schedule 13G FIlings of Dentsply Sirona

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2023
generation investment management llp
2.21%
4,747,746
SC 13G/A
Feb 09, 2023
vanguard group inc
11.69%
25,121,756
SC 13G/A
Feb 08, 2023
nuance investments, llc
5.88%
12,642,319
SC 13G
Feb 03, 2023
blackrock inc.
7.9%
16,978,584
SC 13G/A
Mar 09, 2022
blackrock inc.
10.9%
23,745,567
SC 13G/A
Feb 14, 2022
generation investment management llp
5.26%
11,504,992
SC 13G/A
Feb 09, 2022
vanguard group inc
10.91%
23,855,927
SC 13G/A
Feb 04, 2022
artisan partners limited partnership
5.2%
11,339,948
SC 13G/A
Feb 01, 2022
blackrock inc.
8.1%
17,700,553
SC 13G/A
Dec 30, 2021
generation investment management llp
5.26%
11,504,992
SC 13G

Recent SEC filings of Dentsply Sirona

View All Filings
Date Filed Form Type Document
Sep 13, 2023
4
Insider Trading
Sep 13, 2023
8-K
Current Report
Aug 10, 2023
4
Insider Trading
Aug 10, 2023
4
Insider Trading
Aug 07, 2023
10-K/A
Annual Report
Aug 07, 2023
10-Q
Quarterly Report
Aug 07, 2023
10-Q/A
Quarterly Report
Aug 02, 2023
8-K
Current Report
Jul 26, 2023
3
Insider Trading
Jul 17, 2023
4
Insider Trading

Peers (Alternatives to Dentsply Sirona)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
109.7B
19.5B
5.69% 32.97%
40.5
5.64
10.36% 30.30%
108.4B
31.6B
1.36% -7.86%
29.89
3.44
1.57% -30.40%
102.6B
6.7B
4.79% 48.19%
71.98
15.39
11.75% -0.66%
71.3B
19.0B
-2.82% 6.66%
44.09
3.79
0.46% -5.24%
43.7B
5.7B
-4.65% -17.80%
31.48
7.73
5.64% -4.53%
MID-CAP
10.1B
937.8M
4.57% 35.10%
345.25
10.72
16.30% 250.21%
7.7B
616.6M
-5.28% -28.68%
31.46
12.45
69.52% 343.68%
5.3B
1.1B
-3.27% -11.90%
25.23
4.84
12.63% 50.85%
2.7B
452.1M
-15.03% -38.95%
-27.51
6.04
24.99% 24.09%
1.4B
790.3M
-24.48% -59.71%
-6.39
1.81
3.21% -1604.53%
SMALL-CAP
952.1M
780.7M
-7.16% -11.41%
-26.45
1.22
4.68% -510.17%
839.3M
239.8M
0.70% 0.15%
-22.16
3.5
-4.74% -31.15%
637.3M
162.9M
-22.73% -61.80%
-12.05
3.91
42.67% 12.82%
551.7M
162.2M
18.78% -45.96%
-6.56
3.4
9.71% 12.37%

Dentsply Sirona News

MarketWatch
Dentsply Sirona Inc. stock outperforms competitors despite losses on the day.
MarketWatch,
3 hours ago
Insider Monkey
Clayton County Register
Investor's Business Daily

Returns for XRAY

Cumulative Returns on XRAY

-1.6%


10-Year Cumulative Returns

-6.6%


7-Year Cumulative Returns

-1.1%


5-Year Cumulative Returns

-8.1%


3-Year Cumulative Returns

Risks for XRAY

What is the probability of a big loss on XRAY?

71.9%


Probability that Dentsply Sirona stock will be more than 20% underwater in next one year

52.3%


Probability that Dentsply Sirona stock will be more than 30% underwater in next one year.

45.4%


Probability that Dentsply Sirona stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does XRAY drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Dentsply Sirona was unfortunately bought at previous high price.

Drawdowns

Financials for Dentsply Sirona

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Last 12 Months)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue0.1%3,936,0003,931,0003,922,0004,042,0004,135,0004,174,0004,231,0004,204,0004,047,0003,484,0003,339,0003,374,5003,453,6003,964,0004,029,2003,977,4003,943,7003,976,4003,986,3004,017,6004,098,400
Gross Profit-1.5%2,094,0002,125,0002,127,0002,214,0002,275,0002,289,0002,347,0002,310,0002,173,0001,760,0001,656,0001,699,6001,781,6002,140,4002,165,1002,079,3002,041,4002,053,4002,067,8002,136,3002,219,200
  S&GA Expenses0.4%1,635,0001,629,0001,589,0001,564,0001,558,0001,541,0001,551,0001,547,0001,465,0001,331,0001,302,0001,253,9001,340,2001,512,1001,587,0001,695,2001,714,4001,715,7001,719,0001,707,8001,719,800
  R&D Expenses2.3%179,000175,000174,000180,000178,000176,000171,000160,000150,000127,000123,000113,333112,000144,000143,000------
EBITDA100.0%--972,000-866,000-725,000627,000-970,000--608,100322,000315,400347,500512,000697,200648,500576,800-631,500---
EBITDA Margin100.0%--0.25*-0.22*-0.17*0.15*-0.23*--0.17*0.10*0.09*0.10*0.13*0.17*0.16*0.15*-0.16*---
Interest Expenses7.8%83,00077,00070,00062,00062,00062,00064,00057,00057,00053,00045,00039,00031,60028,60030,00032,10035,20036,80037,00037,50037,600
Earnings Before Taxes-3.8%-1,215,000-1,170,000-1,055,000-907,000447,000487,000545,000518,000462,000217,000-50,000-48,900600162,200338,000285,700210,900-999,000-958,000-1,748,700-1,682,800
EBT Margin100.0%--0.30*-0.27*-0.21*0.11*-0.13*0.13*0.12*0.06*-0.02*-0.01*0.00*0.04*0.09*0.07*-----
Net Income1.2%-1,029,000-1,042,000-950,000-816,000345,000368,000411,000397,000360,000172,000-74,000-76,700-38,70089,700262,900162,400105,400-1,053,000-1,011,000-1,663,200-1,600,600
Net Income Margin100.0%--0.26*-0.24*-0.19*0.09*-0.10*0.10*0.09*0.05*-0.02*-0.02*-0.01*0.02*0.07*0.04*-----
Free Cashflow-100.0%-254,000368,000375,000266,000-515,000--607,000548,000547,800499,800470,500509,800353,200319,700291,500---
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets-0.3%7,6507,6737,6437,5228,9489,1729,2399,2899,3789,1379,3508,8968,6048,0588,6038,3678,5758,6058,6878,7698,822
  Current Assets-1.2%1,9201,9431,8931,9391,8851,8971,8521,8051,7851,6961,7982,5802,3631,8052,0001,8111,8281,7961,8881,9031,892
    Cash Equivalents-7.2%2953183654183623743392813323184381,2721,109236405226250225310233239
  Inventory-0.3%6576596275925815535155485391.00476489549591562605608618599672666
  Net PPE0.3%772770761714744771773771769758791772772777802783820854871866858
  Goodwill0.1%2,7032,7012,6882,5843,8583,9443,9764,0004,0333,9523,9863,2833,2273,1923,3973,3563,4133,3993,4313,4443,458
Liabilities-2.2%3,9484,0353,8313,9084,1104,3084,2424,2264,3014,2074,4154,1343,9593,3683,5083,3083,3923,4953,5543,6153,682
  Current Liabilities-7.5%1,2711,3741,1701,2961,2411,3721,2611,1991,2511,2121,3721,1787638929958698818711,0131,0801,118
    LT Debt, Non Current-0.1%1,8411,8421,8261,7371,8071,8721,9131,9251,9461,9231,9781,9302,1831,4211,4331,4041,4411,5451,5651,5751,587
Shareholder's Equity1.9%3,7063,6383,8113,6134,8384,8644,9975,0635,0344,8904,9354,7204,6084,6495,0485,0595,1835,1105,0835,1545,140
  Retained Earnings13.8%4634074564981,6021,5561,5141,4191,4021,3281,1981,1561,1251,2421,4041,3241,2621,2451,2261,2441,216
  Additional Paid-In Capital0.7%6,6486,6046,6296,6196,6176,5736,6066,6596,6386,6186,6046,5926,5776,5546,5876,5676,5516,5206,5226,5296,526
Shares Outstanding-0.4%212213215215215217217219218219219219219221221223224223223222225
Minority Interest-33.3%-4.00-3.001.001.001.001.001.003.003.003.003.002.002.003.002.002.002.002.0012.0012.0013.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations-17.1%33440351737526693.00-264485659649691629600639536502474500527565
  Share Based Compensation-12.3%57.0065.0059.0041.0049.0046.0048.0065.0060.0050.0047.0052.0051.0067.0066.0056.0046.0021.0021.0022.0036.00
Cashflow From Investing7.6%-122-132-138-109-83.00-43.00-103-1,204-1,229-1,193-1,106-34.30-24.50-72.30-69.00-87.70-118-220-253-255-254
Cashflow From Financing21.5%-237-302-329-168-162-10.00-53.00-68.00-105553476389266-502-472-449-370-329-250-403-343
  Dividend Payments2.8%11010710410299.0094.0092.0090.0088.0088.0088.0088.0086.0084.0081.0079.0078.0079.0079.0079.0080.00
  Buy Backs0%15015015011026026020090.0090.0090.0014024034040026016060.00250250500500

XRAY Income Statement

2023-06-30
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Net sales$ 1,028$ 1,023$ 2,006$ 1,992
Cost of products sold478442937890
Gross profit5505811,0691,102
Selling, general, and administrative expenses416410832786
Research and development expenses49459590
Restructuring and other costs576410
Operating income8011978216
Other income and expenses:    
Interest expense, net21154027
Other expense (income), net13132011
Income before income taxes469118178
(Benefit) provision for income taxes(39)18(44)36
Net income857362142
Less: Net loss attributable to noncontrolling interest(1)0(5)0
Net income attributable to Dentsply Sirona$ 86$ 73$ 67$ 142
Net income per common share attributable to Dentsply Sirona:    
Basic (in dollars per share)$ 0.41$ 0.34$ 0.31$ 0.66
Diluted (in dollars per share)$ 0.40$ 0.34$ 0.31$ 0.66
Weighted average common shares outstanding:    
Basic (in shares)211.9214.9213.2215.9
Diluted (in shares)213.1215.3214.4216.5

XRAY Balance Sheet

2023-06-30
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current Assets:  
Cash and cash equivalents$ 295$ 365
Accounts and notes receivables-trade, net670632
Inventories, net657627
Prepaid expenses and other current assets298269
Total Current Assets1,9201,893
Property, plant, and equipment, net772761
Operating lease right-of-use assets, net191200
Identifiable intangible assets, net1,8081,903
Goodwill2,7032,688
Other noncurrent assets256198
Total Assets7,6507,643
Current Liabilities:  
Accounts payable265279
Accrued liabilities728727
Income taxes payable1746
Notes payable and current portion of long-term debt261118
Total Current Liabilities1,2711,170
Long-term debt1,8411,826
Operating lease liabilities144149
Deferred income taxes261287
Other noncurrent liabilities431399
Total Liabilities3,9483,831
Commitments and contingencies (Note 14)
Equity:  
Preferred stock, $1.00 par value; 0.25 million shares authorized; no shares issued00
Common stock, $0.01 par value; 400.0 million shares authorized, and 264.5 million shares issued at June 30, 2023 and December 31, 2022 211.7 million and 215.3 million shares outstanding at June 30, 2023 and December 31, 202233
Capital in excess of par value6,6486,629
Retained earnings463456
Accumulated other comprehensive loss(620)(628)
Treasury stock, at cost, 52.8 million and 49.3 million shares at June 30, 2023 and December 31, 2022, respectively(2,788)(2,649)
Total Dentsply Sirona Equity3,7063,811
Noncontrolling interests(4)1
Total Equity3,7023,812
Total Liabilities and Equity$ 7,650$ 7,643
John P. Groetelaars
15000
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces. The company also provides dental CAD/CAM products, digital impressions intraoral scanners, mills, and services; and orthodontic products, including high frequency vibration technology device under the name VPro, dentist-directed clear aligner solutions under the name SureSmile, and direct-to-consumer clear aligner solutions under the name Byte; dental implant products, bone regenerative and restorative solutions, and educational programs; and urology catheters and other healthcare-related consumable products. In addition, it offers endodontic products comprising endodontic instruments and materials, drills, filers, sealers, irrigation needles, and other tools or single-use solutions; restorative products that include dental prosthetics, such as artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products; small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers; and dental supplies, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.